Nomenclature of HBV core protein-targeting antivirals

Fabien Zoulim,Adam Zlotnick,Stephanie Buchholz,Eric Donaldson,John Fry,Anuj Gaggar,Jianming Hu,Michael Kann,Oliver Lenz,Kai Lin,Nagraj Mani,Michael Nassal,William Delaney,Su Wang,Gabriel Westman,Veronica Miller,Harry L. A. Janssen

Nature reviews. Gastroenterology & hepatology（2022）

引用 19|浏览12

暂无评分

摘要

Hepatitis B virus (HBV) core protein-targeting compounds are in or entering clinical development without a standardized nomenclature. We propose a naming convention for these core-targeting antiviral products to provide clarity and accelerate HBV drug development.

查看译文

关键词

Clinical trials,Hepatitis B,Medicine/Public Health,general,Gastroenterology,Hepatology,Biomedicine

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要